AxoSim Speaks at 2024 ADC Toxicity Summit
AxoSim’s Director of Scientific Operations, Megan Terral, gave an oral presentation at the 2nd annual ADC Toxicity Summit titled “High-throughput […]
AxoSim Speaks at 2024 ADC Toxicity Summit Read more
AxoSim’s Director of Scientific Operations, Megan Terral, gave an oral presentation at the 2nd annual ADC Toxicity Summit titled “High-throughput […]
AxoSim Speaks at 2024 ADC Toxicity Summit Read more
Get to know AxoSim’s Director of Scientific Operations Meet Megan Terral, AxoSim’s Director of Scientific Operations. Megan has been with
Q&A With AxoSim’s Megan Terral Read more
Lise Harbom, Nicholas Coungeris, and Corey Rountree present at 2024 MPS World Summit Three AxoSim scientists presented at this year’s
MPS Features Three AxoSim Scientists at 2024 World Summit Read more
NEW ORLEANS, La. (June 11, 2024)—AxoSim, a life science company building human brains in the lab at scale to heal
AxoSim Appoints Alif Saleh as Chief Executive Officer to Drive Market Adoption Read more
The Society of Toxicology (SOT) brought together more than 5,000 people for its 63rd Annual Meeting and ToxExpo March 10
AxoSim Posters Featured at SOT 2024 Annual Meeting  Read more
On Tuesday, October 24, 2023, AxoSim announced the completion of its acquisition of the microBrain™-associated assets of Vyant Bio’s StemoniX
Latest Acquisition Lands AxoSim in the News Read more